You are here: Home » Companies » News
Business Standard

Promius Pharma sells rights of Cloderm cream to EPI Health, LLC: Dr Reddy's

As per terms, Promius Pharma will be paid upfront and get future royalties as consideration for the cream and its generic in the US

BS Reporter  |  Hyderabad 

Dr Reddy's

Dr Reddy's Laboratories Limited announced on Tuesday that its wholly-owned subsidiary has sold its rights of (Clocortolone pivalate) cream, and its authorised generic to EPI Health, LLC.

Under the terms of the agreement, is eligible to receive an upfront payment followed by future royalties as the consideration for the cream and its authorised generic in the US effective immediately, according to the company. EPI group is a privately held company headquartered in Charleston, South Carolina,

"We look forward to EPI continuing to support Cloderm, a brand that providers have prescribed for several decades and find as an important treatment option for their patients," said Anil Namboodripad, senior vice president, Proprietary Products and President,

In 2011 Promius Pharma entered a collaborative agreement with Valeant Pharmaceuticals International, Inc. to manufacture, distribute and market cream in the US by offering an upfront payment and royalties on sale of the product. Cloderm cream contains a medium potency topical corticosteroid and is used for treating dermatitis and other skin conditions.

Dr Reddy's did not elaborate on the reasons for the sale of its rights of Cloderm.

First Published: Tue, October 02 2018. 20:43 IST